Etheros Pharmaceuticals
PrivateLast Round
VC Round
Dec 9, 2025
Total Funding Raised
$950,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Etheros Pharmaceuticals operates in Healthcare & Life Sciences and is based in Nashville, Tennessee. Its latest recorded funding round was a VC Round in December 2025.
Etheros Pharmaceuticals is a drug discovery company developing a new class of small molecule drugs which mimic endogenous enzymes to prevent oxidative and inflammatory injury.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Etheros Pharmaceuticals Comparables
Compare Etheros Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Morningside | 77% | |
| Recursion Pharmaceuticals | 65% | |
| Eli Lilly and Company | 58% |
For institutional investors. Book with your work email.
Etheros Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 9, 2025 | ||||
| Debt | Jun 10, 2025 | ||||
| Seed | Mar 1, 2023 |
For institutional investors. Book with your work email.
Etheros Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Backed VC | Seed, VC Round |
| VitaDAO | Seed |
| Immortal Dragons | VC Round |
| Healthspan Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 9, 2025
Led by Immortal Dragons with participation from Backed VC.
- Jun 10, 2025
$600K debt round raised.
For institutional investors. Book with your work email.
Etheros Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Etheros Pharmaceuticals's valuation, stock price, and market status.
Is Etheros Pharmaceuticals a public or private company?
Etheros Pharmaceuticals is a private company.
What is the current stock price of Etheros Pharmaceuticals?
Etheros Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Etheros Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Etheros Pharmaceuticals worth (valuation)?
Valuation information for Etheros Pharmaceuticals is not publicly available.
Can I buy Etheros Pharmaceuticals stock?
Etheros Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Etheros Pharmaceuticals's last funding round?
Etheros Pharmaceuticals's most recent funding round was VC Round on December 9, 2025.
Who are the main investors in Etheros Pharmaceuticals?
Key investors in Etheros Pharmaceuticals include Immortal Dragons.
Will Etheros Pharmaceuticals IPO soon?
No public IPO plans have been announced for Etheros Pharmaceuticals.
How can I track Etheros Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Etheros Pharmaceuticals's shares on secondary markets.